Cancer
Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy®
10 Oct 2023
Read More
Company Updates
Owlstone Medical Appoints Five Leading Experts to Scientific Advisory Board
Read More
19 Jul 2018
Breath Biopsy
Owlstone Medical provides Breath Biopsy Services to AstraZeneca to study disease drivers in Asthma and COPD
Read More
9 Apr 2018
Breath Biopsy
Owlstone Medical launches Breath Biopsy Kits
Read More
28 Mar 2018
Company Updates
Owlstone Medical raises $15 million USD (£11 million GBP) with Horizons Ventures and Aviva
Read More
5 Mar 2018
Breath Biopsy
Owlstone Medical’s Breath Biopsy Wins Global IPF Catalyst Challenge
Read More
25 Jan 2018
Breath Biopsy
The Economist: Follow Your Nose
Read More
1 Dec 2017
Breath Biopsy
Owlstone Medical’s Breath Biopsy Platform integrated into GSK’s Phase II Respiratory Disease Clinical Trial
Read More
27 Nov 2017
Breath Biopsy
Breath Biopsy® in The Economist’s Cancer Technology Quarterly
Read More
15 Sep 2017
Breath Biopsy
Owlstone Medical’s disease breathalyzer, ReCIVA, to feature in Tomorrow’s World gallery at the Science Museum, London
Read More
22 Aug 2017
Breath Biopsy
Owlstone Medical and Cancer Research UK (CRUK) Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease
Read More
10 Jul 2017
Breath Biopsy
Breath Biopsy® in The Sunday Times – Blow for Cancer
Read More
3 Jul 2017
Company Updates
Owlstone Medical CEO and Breath Biopsy Pioneer Billy Boyle wins Royal Academy of Engineering’s Silver Medal
Read More
29 Jun 2017

Talk to us about your biomarker research and how Breath Biopsy could help.